The purpose of Nyctea Technologies is to increase the efficiency in the production of biological pharmaceuticals.
Antibodies, gene vectors and vaccines are effective treatments against a growing number of diseases. However, they are expensive to produce and slow to develop restricting global access to the best available pharmaceuticals. The main contributor to the cost of production, is the separation of the pharmaceutical compound from other biomolecules made by the cells during harvest.
Nyctea Technologies develops an electrode filter that can capture and release biopharmaceuticals by electronic signals. This enables a new and more efficient method of separation between biological molecules, which can increase the speed and control in development and production of life saving treatments.
The long-term ambition is to create the next generation digitalized and automated systems for every step in the biomedical industry, from production and analysis to diagnostics and drug-delivery.